CJC-1295 with DAC
CJC-1295 with DAC (GHRH analogue)
About
Specifications
Dosing
A healthy-adult study examined single subcutaneous doses of 30–250 μg/kg and separate multiple-dose cohorts.
Full dosing guideTitration schedule · referenceCJC-1295 with DAC (GHRH analogue)
A healthy-adult study examined single subcutaneous doses of 30–250 μg/kg and separate multiple-dose cohorts.
Full dosing guideTitration schedule · referenceAnalytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
CJC-1295 with DAC is a synthetic growth-hormone-releasing-hormone (GHRH) analogue that has become one of the go-to tools in GH-axis research protocols. Built on the GRF(1-29) fragment, four amino-acid substitutions protect the molecule from DPP-4 cleavage, while the DAC (Drug Affinity Complex, a maleimide group) binds covalently to plasma albumin — the distinction from CJC-1295 without DAC, and what extends the half-life from minutes to days in research models.
Studied for raising baseline GH and IGF-1 while preserving the pulsatile character of secretion. It acts through the GHRH receptor — a pathway distinct from secretagogues such as GHRP-6.
Supplied as a lyophilized powder; every batch is assayed by HPLC.
No reviews yet
Bought this product? Be the first to tell others — it takes a minute.